Web Analytics

3 Latest Announced Rounds

  • $582,532,500
    Unknown

    4 Investors

    Technology, Information and Internet
    Dec 5th, 2025
  • $18,000,000
    Seed

    1 Investors

    Computer & Network Security
    Dec 5th, 2025
  • $28,000,000
    Unknown

    3 Investors

    Computer & Network Security
    Dec 5th, 2025
$3,601.59M Raised in 63 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Kate Therapeutics

start up
United States - San Diego, California
  • 08/06/2023
  • Series A
  • $51,000,000

Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.


Related People

Kevin ForrestFounder

Kevin Forrest United States - San Diego, California

N/A